Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ALNY save search
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
Published: 2023-04-10 (Crawled : 12:00) - biospace.com/
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: 2.73%
H: 2.21%
C: -3.98%
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: -0.91%
H: 0.38%
C: -4.84%
EDIT | $5.5 -0.9% -0.91% 2.3M
|
Health Technology
|
| O: -1.01%
H: 0.29%
C: -3.21%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.49%
H: 0.09%
C: -0.89%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: -2.16%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: -2.05%
therapeutics
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
Published: 2023-03-09 (Crawled : 13:00) - biospace.com/
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.59%
H: 1.36%
C: -1.76%
partnership pharmaceuticals expansion pharma collaboration therapeutics
Alnylam Announces Appointment of Peter Kellogg to Board of Directors
Published: 2023-03-08 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
PEP | $174.1 1.06% 1.05% 6.6M
|
Consumer Non-Durables
|
| O: 0.02%
H: 0.39%
C: 0.25%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.0%
H: 0.35%
C: -0.7%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.31%
H: 0.68%
C: -1.72%
kellogg
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-23 (Crawled : 22:00) - globenewswire.com
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.18%
H: 0.23%
C: -2.9%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -6.24%
H: 0.08%
C: -4.98%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -2.28%
H: 4.07%
C: -1.04%
year financial update results
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Period Activity
Published: 2023-02-23 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -1.54%
H: 2.08%
C: -0.89%
pharmaceuticals year financial results
Pozelimab (C5 Antibody) BLA for Treatment of Children and Adults with Ultra-rare CHAPLE Disease Accepted for FDA Priority Review
Published: 2023-02-21 (Crawled : 15:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.09%
H: 0.59%
C: -0.21%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -2.68%
H: 0.6%
C: -7.83%
treatment fda disease children review
Alnylam Announces U.S. Food and Drug Administration (FDA) Acceptance of Supplemental New Drug Application for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
Published: 2023-02-21 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -2.68%
H: 0.6%
C: -7.83%
onpattro treatment drug application food
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.31%
H: 2.38%
C: 1.84%
conference year financial results
Global Hemoglobinopathies Market Report 2022: Rising Cases in Under-Developed Countries Boosts Growth
Published: 2023-01-16 (Crawled : 14:00) - prnewswire.com
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
| Email alert
Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
EMMA | $0.1138 385.44% 300
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
| Email alert
Add to watchlist
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GBT | $68.49 0.02% -0.02%
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
global report growth market
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes
Published: 2022-12-21 (Crawled : 13:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 6.05%
H: 2.65%
C: 0.66%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.63%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.05%
H: 2.34%
C: 1.64%
treatment application diabetes
Alnylam Announces 2023 Product and Pipeline Goals and Provides Program Updates at R&D Day
Published: 2022-12-15 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: -1.56%
day program
RNAi Technology Global Market to Reach $3.5 Billion by 2028 at a CAGR of 10.1%
Published: 2022-12-12 (Crawled : 22:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 2.32%
H: 0.0%
C: 0.0%
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: 1.63%
H: 13.76%
C: -6.11%
PHIO | $0.631 -1.07% -1.08% 29K
|
Health Technology
|
| O: -4.12%
H: 6.87%
C: 1.78%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 1.46%
H: 0.99%
C: -0.97%
global technology market
Alnylam Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration (FDA) for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
Published: 2022-12-08 (Crawled : 22:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.43%
H: 3.16%
C: 2.44%
onpattro treatment drug application food
Alnylam to Webcast Virtual R&D Day
Published: 2022-12-08 (Crawled : 13:00) - biospace.com/
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.43%
H: 3.16%
C: 2.44%
day
Alnylam Ranks #1 on Boston Globe’s Top Places to Work List for 2022
Published: 2022-12-01 (Crawled : 13:00) - biospace.com/
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.11%
H: 1.38%
C: -0.05%
work
Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
EMMA | $0.1138 385.44% 300
|
Professional, Scientific, and T...
|
| O: 33.02%
H: 0.0%
C: -21.11%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -5.8%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.74%
H: 0.89%
C: 0.53%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.32%
H: 1.21%
C: 0.09%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.13%
H: 1.13%
C: 0.14%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: 0.0%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: -1.1%
H: 1.66%
C: -0.28%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.22%
H: 2.19%
C: -5.13%
global report market
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection
Published: 2022-11-06 (Crawled : 16:20) - globenewswire.com
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
| Email alert
Add to watchlist
VIR | $7.96 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
vir-2218 hepatitis virus potential infection chronic hepatitis b
Regeneron Reports Third Quarter 2022 Financial and Operating Results
Published: 2022-11-03 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.7%
H: 0.29%
C: 0.29%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.85%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -1.95%
H: 2.27%
C: 1.74%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -0.25%
H: 3.94%
C: 1.26%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -1.74%
H: 4.61%
C: 2.42%
financial results
DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space
Published: 2022-11-01 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -4.49%
H: 3.81%
C: 1.95%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.95%
H: 2.66%
C: -0.1%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 1.1%
H: 3.4%
C: -1.36%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 1.06%
H: 2.53%
C: 1.75%
space pharma companies set
Alnylam Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity
Published: 2022-10-27 (Crawled : 13:00) - biospace.com/
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -1.75%
H: 1.26%
C: -1.77%
pharmaceuticals financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.